MSEPX
Price
$25.21
Change
-$0.17 (-0.67%)
Updated
Oct 7 closing price
Net Assets
190.27M
RNWBX
Price
$90.96
Change
-$0.29 (-0.32%)
Updated
Oct 7 closing price
Net Assets
75.16B
Interact to see
Advertisement

MSEPX vs RNWBX

Header iconMSEPX vs RNWBX Comparison
Open Charts MSEPX vs RNWBXBanner chart's image
Morgan Stanley Inst Emerging Mkts C
Price$25.21
Change-$0.17 (-0.67%)
VolumeN/A
Net Assets190.27M
American Funds New World R2
Price$90.96
Change-$0.29 (-0.32%)
VolumeN/A
Net Assets75.16B
MSEPX vs RNWBX Comparison Chart in %
View a ticker or compare two or three
VS
MSEPX vs. RNWBX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEPX is a Buy and RNWBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 75.2B vs. MSEPX (190M). MSEPX pays higher dividends than RNWBX: MSEPX (0.15) vs RNWBX (0.12). MSEPX was incepted earlier than RNWBX: MSEPX (10 years) vs RNWBX (23 years). MSEPX (3.13) is less costly to investors than RNWBX (1.67). MSEPX is a more actively managed with annual turnover of: 41.00 vs. RNWBX (37.00). RNWBX has a lower initial minimum investment than MSEPX: RNWBX (250) vs MSEPX (1000). MSEPX annual gain was more profitable for investors over the last year : 16.16 vs. RNWBX (11.48). RNWBX return over 5 years is better than : 25.41 vs. MSEPX (15.05).
MSEPXRNWBXMSEPX / RNWBX
Total Expense Ratio2.101.67126%
Annual Report Gross Expense Ratio3.131.67187%
Fund Existence10 years23 years-
Gain YTD27.02723.671114%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets190M75.2B0%
Annual Yield % from dividends0.150.12128%
Returns for 1 year16.1611.48141%
Returns for 3 years55.4654.43102%
Returns for 5 years15.0525.4159%
Returns for 10 years27.6786.1932%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVRX16.64N/A
N/A
Lord Abbett Fundamental Equity R3
SOPAX32.10N/A
N/A
ClearBridge Dividend Strategy A
EMECX13.36N/A
N/A
Ashmore Emerging Markets Equity C
FIJFX93.71N/A
N/A
Fidelity Advisor Materials Z
CTAGX17.27-0.11
-0.63%
Calamos Timpani SMID Growth A